Evidence map›Paper›PMID 35071057›Full record

ReviewFrontiers in cellular and infection microbiology2021

Molecular Mechanisms of

Lalitha Biswas, Friedrich Götz

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in cellular and infection microbiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 59 papers.

0numbers the graph read from it
0cells of the map it votes in
59citing papers in PubMed
12.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

59 citing papers in PubMed, 85 citations in OpenAlex.

  1. Microenvironment shapesiScience · 2026
    Article
  2. MRSA-dominant colonization and synergistic pathogenicity withJournal of orthopaedic translation · 2026
    Article
  3. Article
  4. bioRxiv : the preprint server for biology · 2026
    Article
  5. Article
  6. ERJ open research · 2026
    Review
  7. Article
  8. Article
  9. BioMed research international · 2026
    Review
  10. Amoebicidal effect of pyocyanin and its mechanism of action againstCurrent research in parasitology & vector-borne diseases · 2026
    Article
  11. Review
  12. Investigating the cardioprotective effects ofBiochemistry and biophysics reports · 2025
    Article
  13. Article
  14. Journal of bacteriology · 2025
    Article
  15. Journal of bacteriology · 2025
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. NorA and Tet38 efflux pumps enableAntimicrobial agents and chemotherapy · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 2 countries.

Lalitha BiswasCentre for Nanosciences and Molecular Medicine, Amrita Vishwa Vidyapeetham, Kochi, India.
Friedrich GötzMicrobial Genetics, Interfaculty Institute of Microbiology and Infection Medicine Tübingen (IMIT), University of Tübingen, Tübingen, Germany.
Amrita Vishwa Vidyapeetham · INUniversity of Tübingen · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cystic fibrosis (CF) is an autosomal recessive genetic disorder that is characterized by recurrent and chronic infections of the lung predominantly by the opportunistic pathogens, Gram-positive

Indexed as

Cystic FibrosisPseudomonas InfectionsStaphylococcal InfectionsAntimicrobial PeptidesChild, PreschoolHumansLungPersistent InfectionPseudomonasPseudomonas aeruginosaStaphylococcusStaphylococcus aureusAntimicrobial Peptidesadaptationantagonismco-existencecystic fibrosisPseudomonas aeruginosaStaphylococcus aureus

Identifiers

PMID35071057
PMCPMC8770549
OpenAlexW4205718327

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.